stages of the disease can open up new directions for treatment interventions and
modificationBALTINA, L.A.,
SAPOZHNIKOVA, T.A.,
GABDRAKHMANOVA, S.F.,
MAKARA, N.S.,
ZARUDII, F.A.,
KONDRATENKO, R.M. (2020) -hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. Chemical
modification of GA via addition of L
Enikeeva, Kadriia,
Rafikova, Guzel,
Sharifyanova, Yuliya,
Mulyukova, Diana,
Vanzin, Alexandr,
Pavlov, Valentin (2024) such as CpG island methylation, histone
modification, and microRNAs as biomarkers will improve the diagnosis
Urakov, Aleksandr L.,
Tyurin, Anton V.,
Shchekin, Vlas S.,
Siddikov, Olim A.,
Abdurakhmanov, Ilhomjon R.,
Gabdrakhimova, Renata A.,
Samorodov, Aleksandr V. (2024) of diseases is assigned to the mechanisms of epigenetic regulation and posttranslational
modificationsKovalev, A,
Sufianov, R,
Prevedello, D,
Borba, L,
Mastronardi, L,
Ilyasova, T,
Daniel, RT,
Messerer, M,
Rassi, M,
Zhang, G (2022) described),
modifications that allow you to work more targeted, depending on the nature of the neoplasm
Sufianov, A.,
Beilerli, A.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Bessonova, M.,
Mashkin, A.,
Beylerli, O. (2023) by modulating the levels of visible
modification, transcription, post-transcription, and biological environment
Klen, E.E.,
Makarova, N.N.,
Khaliullin, F.A.,
Shepilova, S.O.,
Ishkinina, A.R.,
Baikova, I.P. (2022) for further transformations. Possible
modifications of the title compounds via oxidation to 1-(1-oxo-λ4
Дьяконов, В.А.,
Джемилева, Л.У.,
Джемилев, У.М.,
D'yakonov, V.A.,
Dzhemileva, L.U.,
Dzhemilev, U.M. (2017) topoisomerase inhibitors, their
modification aimed at improving the properties, the study of mechanisms